Immediate Impact
10 from Science/Nature 63 standout
Citing Papers
LAG-3, TIM-3, and TIGIT: Distinct functions in immune regulation
2024 Standout
New promises and challenges in the treatment of advanced non-small-cell lung cancer
2024 Standout
Works of W. Fox being referenced
ARC-7: Randomized phase 2 study of domvanalimab + zimberelimab ± etrumadenant versus zimberelimab in first-line, metastatic, PD-L1-high non-small cell lung cancer (NSCLC).
2022
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| W. Fox | 1176 | 1405 | 353 | 366 | 101 | 2.4k | |
| T. Rauch | 172 | 1986 | 163 | 950 | 197 | 4.1k | |
| M. E. Austin | 3826 | 2402 | 60 | 111 | 242 | 4.4k | |
| R. A. Cairns | 933 | 2071 | 150 | 169 | 122 | 3.2k | |
| M. McCarthy | 490 | 3515 | 26 | 835 | 135 | 4.0k | |
| Cha‐Mei Tang | 633 | 193 | 275 | 215 | 139 | 2.5k | |
| T. Murakami | 2099 | 404 | 30 | 171 | 196 | 3.7k | |
| A. Mushtaq | 222 | 1385 | 43 | 103 | 208 | 2.8k | |
| G. Laval | 2109 | 1217 | 821 | 172 | 90 | 3.3k | |
| Brandon Carter | 2763 | 3618 | 29 | 401 | 79 | 4.8k | |
| Troy Carter | 1629 | 1673 | 74 | 294 | 97 | 2.5k |
All Works
Login with ORCID to disown or claim papers
Loading papers...